Skip To The Main Content

FDA Issues Regulatory Update for Health Professionals

The United States Food and Drug Administration (FDA) has issued an update on its regulatory activities aimed at health care professionals.  The update highlights the FDA MedWatch adverse event reporting program and a series of free Webinars explaining the program, funding requests to support health care innovation and broadening patient access to health care, and protecting human subjects in clinical trials.  To read the FDA regulatory update for health care professionals, use the link below.